Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
UBS
US Army
Colorcon
Dow
Express Scripts
Deloitte
McKinsey
Julphar

Generated: January 24, 2018

DrugPatentWatch Database Preview

Hydroflumethiazide; reserpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydroflumethiazide; reserpine and what is the scope of hydroflumethiazide; reserpine freedom to operate?

Hydroflumethiazide; reserpine
is the generic ingredient in four branded drugs marketed by Usl Pharma, Watson Labs, Ivax Pharms, Par Pharm, and Shire, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroflumethiazide; reserpine.
Summary for hydroflumethiazide; reserpine

US Patents and Regulatory Information for hydroflumethiazide; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDROFLUMETHIAZIDE AND RESERPINE hydroflumethiazide; reserpine TABLET;ORAL 088110-001 Mar 22, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HYDROFLUMETHIAZIDE AND RESERPINE hydroflumethiazide; reserpine TABLET;ORAL 088127-001 Mar 22, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Shire SALUTENSIN hydroflumethiazide; reserpine TABLET;ORAL 012359-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Shire SALUTENSIN-DEMI hydroflumethiazide; reserpine TABLET;ORAL 012359-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088907-001 Sep 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088932-001 Jan 11, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma HYDROFLUMETHIAZIDE AND RESERPINE hydroflumethiazide; reserpine TABLET;ORAL 088195-001 Oct 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
Merck
Teva
Daiichi Sankyo
QuintilesIMS
Baxter
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot